Showing results (121-130 of 225) with videos related to

Sort By:
Pageof 23
The Journal of Rheumatology|January 30, 2010
Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trialsRonald F van Vollenhoven, Paul Emery, Clifton O Bingham, et al.
The Journal of Rheumatology|January 17, 2019
MRI and Dose Selection in a Phase II Trial of Baricitinib with Conventional Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid ArthritisCharles Peterfy, Julie DiCarlo, Paul Emery, et al.
Annals of the Rheumatic Diseases|November 9, 2012
Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patientsRonald F van Vollenhoven, Paul Emery, Clifton O Bingham, et al.
The Journal of Rheumatology|October 3, 2014
Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritisLillian Barra, Janet E Pope, John E Orav, et al.
The Journal of Rheumatology|October 3, 2012
Multiple courses of rituximab produce sustained clinical and radiographic efficacy and safety in patients with rheumatoid arthritis and an inadequate response to 1 or more tumor necrosis factor inhibitors: 5-year data from the REFLEX studyEdward C Keystone, Stanley B Cohen, Paul Emery, et al.
RMD Open|June 9, 2021
Efficacy and safety of tofacitinib modified-release 11 mg once daily plus methotrexate in adult patients with rheumatoid arthritis: 24-week open-label phase results from a phase 3b/4 methotrexate withdrawal non-inferiority study (ORAL Shift)Stanley B Cohen, Janet Pope, Boulos Haraoui, et al.
The Journal of Rheumatology|December 17, 2015
Safety and Efficacy of Subcutaneous Golimumab in Patients with Active Rheumatoid Arthritis despite Methotrexate Therapy: Final 5-year Results of the GO-FORWARD TrialEdward C Keystone, Mark C Genovese, Stephen Hall, et al.
Arthritis Research & Therapy|August 16, 2020
Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritisJosef S Smolen, Young Mo Kang, Wan-Hee Yoo, et al.
Musculoskeletal Care|January 31, 2013
Similar problem in the activities of daily living but different experience: a qualitative analysis in six rheumatic conditions and eight European countriesTanja Stamm, Robin Hieblinger, Carina Boström, et al.
Annals of the Rheumatic Diseases|March 11, 2016
The changing landscape of biosimilars in rheumatologyThomas Dörner, Vibeke Strand, Paul Cornes, et al.
Pageof 23